Immunotherapy Toxicities:  A New Electronic Documentation Template to Improve Patient Care.
Emerging immunotherapies are associated with numerous toxicities. Although traditional health records allow nurses to document system-based assessments, few offer immunotherapy-based documentation templates to assess and grade toxicities. .



The aim of this article is to present the development of a standardized template for documenting genetically modified cellular product-related toxicities in an electronic health record (EHR). .



Through interprofessional collaboration, a documentation template for genetically modified cellular product-related toxicities was developed in an EHR, allowing for standardized documentation, data reporting, and tracking of immune-related toxicities.  .



The documentation template has enhanced the quality and safety of practice at the authors' institution and provides a framework for other nursing units when initiating immunotherapy care. .
University of Texas MD Anderson Cancer Center.
Elizabeth
E
Reimschissel
University of Texas MD Anderson Cancer Center.
Buenagracia
B
Dela Cruz
University of Texas MD Anderson Cancer Center.
Melissa
M
Gonzalez
University of Texas MD Anderson Cancer Center.
Joaquin
J
Buitrago
University of Texas MD Anderson Cancer Center.
Cary
C
Goodman
University of Texas MD Anderson Cancer Center.
Patricia A
PA
Johnston
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D064987:Cell- and Tissue-Based Therapy / Q000009:adverse effects*; D004282:Documentation / Q000592:standards*; D004509:Education, Nursing, Continuing / Q000458:organization & administration; D057286:Electronic Health Records / Q000592:standards*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D009737:Nursing Records / Q000592:standards; D005791:Patient Care / Q000592:standards*
documentation; electronic health records; immunotherapy; toxicity